According to the report published by Visiongain, the Aortic Aneurysm market is forecast at USD 3.2 billion in 2020 and a CAGR of 8.7 percent is anticipated from 2020 to 2030. Increasing geriatric population, bad dietary habits and elevated incidence of cardiovascular diseases (CVDs) are some of the variables that fuel requirement for new thoracic and abdominal aneurysm restoration medicines and equipment that, in fact, are supposed to boost the industry. Smoking is also adding to the development of this industry, which has become a worldwide issue. In specific, low- and middle-income nations experience significant smoking issues owing to absence of knowledge of the damaging environmental impacts of smoking and related danger of creating aneurysm. Scenarios for legislative and reimbursement differ across areas.
At a moment when distribution of this technique had just crossed its turning point, greater patient rivalry is considerably connected with enhanced EVAR implementation. Hospital rivalry does not affect the results of post-AAA restoration. These findings indicate that acceptance of new vascular technology is not guided exclusively by clinical signs, but may also be affected by market forces. These findings may assist direct potential healthcare policies intended to reduce rising expenses connected with the growth of vascular technology.
The development of the worldwide abdominal aortic aneurysm (AAA) repair equipment industry has been enhanced by an rise in the worldwide geriatric population, an rise in tobacco customers, favourable reimbursements, and technological advances. However, elevated costs and hazards connected with the developing nations ‘ processes and absence of understanding hamper the development of the industry. On the opposite, in the close future, increased consciousness of AAA is anticipated to generate profitable possibilities. Over moment, anneurysms can develop in magnitude. It can begin to trigger signs as an aneurysm grows. If an aneurysm becomes too big, it can break and trigger life-threatening injuries or immediate death — without any notice. In the aneurysm, a blood clot may also shape. Small blood clot parts can fall off and spread all over the flesh. It can trigger stroke or heart attack if a portion of a clot comes stuck in a blood vessel of the brain or cardiac. A bit of blood clot may interrupt ordinary work in other essential organs, such as the kidneys or liver. At the least, a clot fragment that blocks blood flow in the legs, feet or arm can cause numbness, weakness, tingling, or coldness, light-headedness or localized pain.
Currently Available Custom-Made Devices
Broadly speaking, the most frequently used conventional endovascular aneurysm surgery (EVAR) and endovascular thoracic aneurysm surgery (TEVAR) systems are custom-made in some respects. Even though each personal element is specified in infra-renal EVAR or TEVAR, the unit produced in vitro is a composite of these parts into a full endograft that is custom-made for each person by some means. The exercise of mixing distinct parts from distinct instrument producers to accomplish a fix in the personal nurse is sometimes implemented off-label and goes one stage further with this “customization”.
However, the term custom-made is used for the purposes of this article to describe specifically ordered endografts that are tailored to the anatomy of the individual patient and can not be achieved simply by combining standard devices available. In most cases, this will involve endovascular stent grafts used to treat side branches of the aorta (e.g., thoracoabdominal, juxtarenal, and suprarenal aneurysms) and aortic arch repair areas. Although customization will in some times only require getting the diameter bigger or lower or altering the endograft’s general size. We address several producers of stent graft which on demand will provide tailored equipment.
Why you should buy Aortic Aneurysm Market Forecast 2020-2030: Forecasts and Analysis By Type (TAA, AAA), By Treatment (Open Surgical Repair, Endovascular Aneurysm Repair), By Product (Stent Graft, Catheter), By End Use (ASC, Hospital) and Geography, with Profiles of Leading Companies
What is the future of the Aortic Aneurysm market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information
– View Aortic Aneurysm market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Aortic Aneurysm revenue forecast
– Aortic Aneurysm connections forecast
– Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Aortic Aneurysm market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Aortic Aneurysm sector
– Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Aortic Aneurysm industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Aortic Aneurysm submarkets with individual forecasts and analysis from 2020-2030.
– Product submarket forecast 2020-2030
– Type submarket forecast 2020-2030
– Treatment submarket forecast 2020-2030
– Learn about the market prospects for the leading Aortic Aneurysm market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Aortic Aneurysm revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Product Revenue Forecast 2020-2030
– Balloon Inflation Devices Market Forecast, 2020-2030
– Vascular Closure Devices Market Forecast, 2020-2030
– Guidewire Market Forecast, 2020-2030
– Catheter Market Forecast, 2020-2030
– Synthetic Stent Graft Market Forecast, 2020-2030
– Stent Graft Market Forecast, 2020-2030
– Type Revenue Forecast 2020-2030
– Thoracic Aortic Aneurysm Market Forecast, 2020-2030
– Abdominal Aortic Aneurysm Market Forecast, 2020-2030
– Other Type Market Forecast, 2020-2030
– Treatment Revenue Forecast 2020-2030
– Open Surgical Repair (OSR) Market Forecast, 2020-2030
– Endovascular Aneurysm Repair (EVAR) Market Forecast, 2020-2030
– Other Treatment Market Forecast, 2020-2030
– End-Use Revenue Forecast 2020-2030
– Hospitals Market Forecast, 2020-2030
– ASCs and Clinics Market Forecast, 2020-2030
– Other End-Use Market Forecast, 2020-2030
– Product Type Revenue Forecast 2020-2030
– Synthetic Graft System Market Forecast, 2020-2030
– Endovascular Stent Graft System Market Forecast, 2020-2030
– Other Market Forecast, 2020-2030
– Understand the prospects for the 4 regional and the leading 12 national Aortic Aneurysm markets
– where will the highest revenues and opportunities occur?
– Learn about the market potential for Aortic Aneurysm companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
– North America Aortic Aneurysm revenue forecast 2020-2030
– US Aortic Aneurysm revenue forecast 2020-2030
– Canada Aortic Aneurysm revenue forecast 2020-2030
– Mexico Aortic Aneurysm revenue forecast 2020-2030
– North America Aortic Aneurysm by Product revenue forecast 2020-2030
– North America Aortic Aneurysm by Type revenue forecast 2020-2030
– North America Aortic Aneurysm by Treatment revenue forecast 2020-2030
– Asia Pacific Aortic Aneurysm revenue forecast 2020-2030
– China Aortic Aneurysm revenue forecast 2020-2030
– Japan Aortic Aneurysm revenue forecast 2020-2030
– India Aortic Aneurysm revenue forecast 2020-2030
– Australia Aortic Aneurysm revenue forecast 2020-2030
– Rest of Asia Pacific Aortic Aneurysm revenue forecast 2020-2030
– Asia Pacific Aortic Aneurysm by Product revenue forecast 2020-2030
– Asia Pacific Aortic Aneurysm by Type revenue forecast 2020-2030
– Asia Pacific Aortic Aneurysm by Treatment revenue forecast 2020-2030
– European Aortic Aneurysm revenue forecast 2020-2030
– Germany Aortic Aneurysm revenue forecast 2020-2030
– UK Aortic Aneurysm revenue forecast 2020-2030
– France Aortic Aneurysm revenue forecast 2020-2030
– Italy Aortic Aneurysm revenue forecast 2020-2030
– Spain Aortic Aneurysm revenue forecast 2020-2030
– Rest of Europe Aortic Aneurysm revenue forecast 2020-2030
– European Aortic Aneurysm by Product revenue forecast 2020-2030
– European Aortic Aneurysm by Type revenue forecast 2020-2030
– European Aortic Aneurysm by Treatment revenue forecast 2020-2030
– Rest of World Aortic Aneurysm revenue forecast 2020-2030
– Rest of World Aortic Aneurysm by Product revenue forecast 2020-2030
– Rest of World Aortic Aneurysm by Type revenue forecast 2020-2030
– Rest of World Aortic Aneurysm by Treatment revenue forecast 2020-2030
– Explore the factors affecting Aortic Aneurysm product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
– Identify who the leading companies are in the Aortic Aneurysm industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Aortic Aneurysm companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Aortic Aneurysm Market
Cook Medical (Cook Group)
Gore Medical (W. L. Gore & Associates)
Microport Scientific Corporation
MAQUET (Getinge Group)
Lombard Medical
JOTEC (CryoLife, Inc.)
Endologix
Terumo Corporation
W.L. Gore and Associates
Endologix, Inc.,
Discover Information found nowhere else in this independent assessment of the Aortic Aneurysm market
The Aortic Aneurysm Market Forecast 2020-2030: Forecasts and Analysis By Product, By Type, By Treatment and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Aortic Aneurysm sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Aortic Aneurysm Market Forecast 2020-2030: Forecasts and Analysis By Product, By Type, By Treatment and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Aortic Aneurysm market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Aortic Aneurysm sector and find out what its future market prospects are.
If you buy our report today your knowledge will stay one step ahead of your competitors. Discover how our report could benefit your research, analyses and strategic decisions, saving you time. To gain an understanding of how to tap into the potential of this market and stay one step ahead of the competition you must order now our report the Aortic Aneurysm Market Forecast 2020-2030: Forecasts and Analysis By Product, By Type, By Treatment and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Aortic Aneurysm sector analysis. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government CCR
Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Report Overview
1.1 Global Aortic Aneurysm Market Definition
1.2 Global Aortic Aneurysm Market Overview
1.3 Global Aortic Aneurysm Market Segmentation
1.4 Research Scope of Aortic Aneurysm in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Aortic Aneurysm Systems Market
2.1 Market Definition
2.2 Industry Structure
2.3 Industry Outlook
2.4 Current Status & Trends
2.4.1 High prevalence of tobacco smoking in the developed and developing region
2.4.2 Rise in the geriatric population
2.4.3 High treatment cost and cost of device
2.4.4 Less treatment options available for thoracic aortic aneurysm repair
2.5 Product Penetration & growth prospect Analysis
2.5.1 Advanced manufacturing process innovation
3. Global Aortic Aneurysm Market Analysis
3.1 PEST Analysis of the Aortic Aneurysm Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Aortic Aneurysm Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.1.1 Powerful Competitive Strategy
3.9.1.2 Firm Concentration Ratio
3.9.1.3 Degree Of Transparency
3.9.2 Supplier Power
3.9.2.1 Supplier Switching Costs Relative To Firm Switching Costs
3.9.2.2 Supplier Concentration To Firm Concentration Ratio
3.9.2.3 Degree Of Differentiation Of Inputs
3.9.3 Buyer Power
3.9.3.1 Degree Of Dependency Upon Existing Channels Of Distribution
3.9.3.2 Buyer Switching Costs Relative To Firm Switching Costs
3.9.3.3 Buyer Concentration To Firm Concentration Ratio
3.9.4 Threat Of Substitute
3.9.4.1 Buyer Propensity To Substitute
3.9.4.2 Relative Price Performance Of Substitute
3.9.4.3 Perceived Level Of Product Differentiation
3..9.5 Threat Of New Entrant
3.9.5.1 Economies Of Scale
3.9.5.2 Switching Costs Or Sunk Costs
3.9.5.3 Industry Profitability (Market CAGR)
4. Aortic Aneurysm: Global Market Analysis by Segments
4.1 Global Aortic Aneurysm Market Forecast, by Product 2020-2030
4.1.1 Product Overview
4.1.2 Balloon Inflation Devices Market Forecast, 2020-2030
4.1.3 Vascular Closure Devices Market Forecast, 2020-2030
4.1.4 Guidewire Market Forecast, 2020-2030
4.1.5 Catheter Market Forecast, 2020-2030
4.1.6 Synthetic Stent Graft Market Forecast, 2020-2030
4.1.7 Stent Graft Market Forecast, 2020-2030
4.2 Global Aortic Aneurysm Market Forecast, by Type 2020-2030
4.2.1 Type Overview
4.2.2 Thoracic Aortic Aneurysm Market Forecast, 2020-2030
4.2.3 Abdominal Aortic Aneurysm Market Forecast, 2020-2030
4.2.4 Other Type Market Forecast, 2020-2030
4.3 Global Aortic Aneurysm Market Forecast, by Treatment 2020-2030
4.3.1 Treatment Overview
4.3.2 Open Surgical Repair (OSR) Market Forecast, 2020-2030
4.3.3 Endovascular Aneurysm Repair (EVAR) Market Forecast, 2020-2030
4.3.4 Other Treatment Market Forecast, 2020-2030
4.4 Global Aortic Aneurysm Market Forecast, by End-Use 2020-2030
4.4.1 End-Use Overview
4.4.2 Hospitals Market Forecast, 2020-2030
4.4.3 ASCs and Clinics Market Forecast, 2020-2030
4.4.4 Other End-Use Market Forecast, 2020-2030
4.5 Global Aortic Aneurysm Market Forecast, by Product Type 2020-2030
4.5.1 Product Type Overview
4.5.2 Synthetic Graft System Market Forecast, 2020-2030
4.5.3 Endovascular Stent Graft System Market Forecast, 2020-2030
4.5.4 Other Market Forecast, 2020-2030
5. Leading Regions in Aortic Aneurysm Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Aortic Aneurysm Market Forecast, 2020-2030
5.2.1 North America Aortic Aneurysm Submarket, By Product Forecast 2020-2030
5.2.2 North America Aortic Aneurysm Submarket, By Type Forecast 2020-2030
5.2.3 North America Aortic Aneurysm Submarket, By Treatment Forecast 2020-2030
5.2.4 North America Aortic Aneurysm Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Aortic Aneurysm Market, Forecast 2020-2030
5.2.4.2 Canada Aortic Aneurysm Market, Forecast 2020-2030
5.2.4.3 Mexico Aortic Aneurysm Market, Forecast 2020-2030
5.3 Europe Aortic Aneurysm Market Forecast, 2020-2030
5.3.1 Europe Aortic Aneurysm Submarket, By Product Forecast 2020-2030
5.3.2 Europe Aortic Aneurysm Submarket, By Type Forecast 2020-2030
5.3.3 Europe Aortic Aneurysm Submarket, By Treatment Forecast 2020-2030
5.3.4 Europe Aortic Aneurysm Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Aortic Aneurysm Market, Forecast 2020-2030
5.3.4.2 Germany Aortic Aneurysm Market, Forecast 2020-2030
5.3.4.3 France Aortic Aneurysm Market, Forecast 2020-2030
5.3.4.4 Italy Aortic Aneurysm Market, Forecast 2020-2030
5.3.4.5 Spain Aortic Aneurysm Market, Forecast 2020-2030
5.3.4.6 The Netherlands Aortic Aneurysm Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Aortic Aneurysm Market, Forecast 2020-2030
5.4 Asia-Pacific Aortic Aneurysm Market Forecast, 2020-2030
5.4.1 Asia-Pacific Aortic Aneurysm Submarket, By Product Forecast 2020-2030
5.4.2 Asia-Pacific Aortic Aneurysm Submarket, By Type Forecast 2020-2030
5.4.3 Asia-Pacific Aortic Aneurysm Submarket, By Treatment Forecast 2020-2030
5.4.4 Asia-Pacific Aortic Aneurysm Submarket, By Country Forecast 2020-2030
5.4.4.1 China Aortic Aneurysm Market, Forecast 2020-2030
5.4.4.2 India Aortic Aneurysm Market, Forecast 2020-2030
5.4.4.3 Japan Aortic Aneurysm Market, Forecast 2020-2030
5.4.4.4 Korea Aortic Aneurysm Market, Forecast 2020-2030
5.4.4.5 Indonesia Aortic Aneurysm Market, Forecast 2020-2030
5.4.4.6 Australia Aortic Aneurysm Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Aortic Aneurysm Market, Forecast 2020-2030
5.5 Rest of World Aortic Aneurysm Market Forecast, 2020-2030
5.5.1 Rest of World Aortic Aneurysm Submarket, By Product Forecast 2020-2030
5.5.2 Rest of World Aortic Aneurysm Submarket, By Type Forecast 2020-2030
5.5.3 Rest of World Aortic Aneurysm Submarket, By Treatment Forecast 2020-2030
6. Leading Companies in The Aortic Aneurysm Market
6.1 Cook Medical
6.1.1 Cook Medical Overview
6.1.2 Analysis of Cook Medical Products and Services
6.1.3 Cook Medical Primary Market Competitors 2019
6.1.4 Cook Medical Key Developments
6.2 Gore Medical
6.2.1 Gore Medical Company Overview
6.2.2 Analysis of Gore Medical Products and Services
6.2.3 Gore Medical Primary Market Competitors 2019
6.2.4 Gore Medical Key Developments
6.3 Microport Scientific Corporation
6.3.1 Microport Scientific Corporation Company Overview
6.3.2 Analysis of Microport Scientific Corporation Products and Services
6.3.3 Microport Scientific Corporation Primary Market Competitors 2019
6.3.4 Microport Scientific Corporation Key Developments
6.4 MAQUET
6.4.1 MAQUET Company Overview
6.4.2 Analysis of MAQUET Products and Services
6.4.3 MAQUET Primary Market Competitors 2019
6.4.4 MAQUET Key Developments
6.5 Lombard Medical
6.5.1 Lombard Medical Company Overview
6.5.2 Analysis of Lombard Medical Products and Services
6.5.3 Lombard Medical Primary Market Competitors 2019
6.5.4 Lombard Medical Key Developments
6.6 JOTEC
6.6.1 JOTEC Company Overview
6.6.2 Analysis of JOTEC Products and Services
6.6.3 JOTEC Primary Market Competitors 2019
6.6.4 JOTEC Key Developments
6.7 Endologix
6.7.1 Endologix Company Overview
6.7.2 Analysis of Endologix Products and Services
6.7.3 Endologix Primary Market Competitors 2019
6.7.4 Endologix Key Developments
6.8 Terumo Corporation
6.8.1 Terumo Corporation Company Overview
6.8.2 Analysis of Terumo Corporation Products and Services
6.8.3 Terumo Corporation Primary Market Competitors 2019
6.8.4 Terumo Corporation Key Developments
6.9 W.L. Gore and Associates
6.9.1 W.L. Gore and Associates Company Overview
6.9.2 Analysis of W.L. Gore and Associates Products and Services
6.9.3 W.L. Gore and Associates Primary Market Competitors 2019
6.9.4 W.L. Gore and Associates Key Developments
6.10 Endologix, Inc.,
6.10.1 Endologix, Inc., Company Overview
6.10.2 Analysis of Endologix, Inc., Products and Services
6.10.3 Endologix, Inc., Primary Market Competitors 2019
6.10.4 Endologix, Inc., Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Aortic Aneurysm Market Segmentation
Figure 2.1 Aortic Aneurysm Value Chain Analysis
Figure 3.1 Aortic Aneurysm Supply-Demand Analysis
Figure 4.1 Global Aortic Aneurysm Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Aortic Aneurysm Market Forecast 2020-2030
Figure 4.3 Global Aortic Aneurysm Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Aortic Aneurysm Market By Product Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.19 Global Aortic Aneurysm by Submarket By Product Forecast 2020-2030 ($ million)
Figure 4.20 Global Aortic Aneurysm Market, by Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.21 Aortic Aneurysm Market, By Type Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Aortic Aneurysm Market, By Treatment System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Aortic Aneurysm Market, By Product Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Aortic Aneurysm Market, By Type Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Aortic Aneurysm Market, by 2020-2030
Figure 5.3 Leading Country/Regional Aortic Aneurysm Market Share, by 2020
Figure 5.4 Leading Country/Regional Aortic Aneurysm Market Share, by 2025
Figure 5.5 Leading Country/Regional Aortic Aneurysm Market Share, by 2030
Figure 5.6 Europe Aortic Aneurysm Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Aortic Aneurysm Market, by Forecast 2020-2030
Figure 5.8 Europe Aortic Aneurysm Submarket, By Product Forecast 2020-2030
Figure 5.9 Europe Aortic Aneurysm Submarket , By Type Forecast 2020-2030
Figure 5.10 Europe Aortic Aneurysm Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Aortic Aneurysm Submarket , By Treatment 2020-2030 ($billion, AGR%)
Figure 5.10 North America Aortic Aneurysm Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Aortic Aneurysm Market, by Forecast 2020-2030
Figure 5.12 North America Aortic Aneurysm Submarket, By Product Forecast 2020-2030
Figure 5.13 North America Aortic Aneurysm Submarket , By Type Forecast 2020-2030
Figure 5.14 North America Aortic Aneurysm Submarket , By Treatment Forecast 2020-2030
Figure 5.13 North America Aortic Aneurysm Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Aortic Aneurysm Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Aortic Aneurysm Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Aortic Aneurysm Submarket, By Product Forecast 2020-2030
Figure 5.17 Asia-Pacific Aortic Aneurysm Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Aortic Aneurysm Submarket , By Treatment Forecast 2020-2030
Figure 5.18 Rest of World Aortic Aneurysm Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Aortic Aneurysm Market, by Forecast 2020-2030
Figure 5.20 Rest of World Aortic Aneurysm Submarket, By Product Forecast 2020-2030
Figure 5.21 Rest of World Aortic Aneurysm Submarket , By Type Forecast 2020-2030
Figure 5.21 Rest of World Aortic Aneurysm Submarket , By Treatment Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Gore Medical Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Microport Scientific Corporation Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 MAQUET Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 MAQUET Revenue % Share, by Treatment Segment, 2019
Figure 6.8 MAQUET Revenue % Share, by Geographical Trade, 2019
Figure 6.9 MAQUET Revenue % Share, by Business Segment, 2019
Figure 6.10 Lombard Medical Revenue % Share, by Geographic Segment, 2019
Figure 6.11 JOTEC Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 Endologix Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 Endologix Revenue % Share, by Regional Segment, 2019
Figure 6.14 Terumo Corporation Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 Terumo Corporation Revenue % Share, by Regional Segment, 2019
Figure 6.16 Terumo Corporation Revenue % Share, by Business Segment, 2019
Figure 6.17 W.L. Gore and Associates Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 Endologix, Inc., Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 Endologix, Inc., Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 Endologix, Inc., Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Aortic Aneurysm Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Aortic Aneurysm Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Aortic Aneurysm Submarket, By Treatment Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Aortic Aneurysm Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Aortic Aneurysm Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Aortic Aneurysm Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Aortic Aneurysm Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Aortic Aneurysm Market Submarket, By Treatment Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Aortic Aneurysm Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Aortic Aneurysm Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Aortic Aneurysm Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Aortic Aneurysm Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Aortic Aneurysm Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Aortic Aneurysm Market Submarket, By Treatment Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Aortic Aneurysm Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Aortic Aneurysm Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Gore Medical Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Gore Medical Products and Services (Product/Service, Segment)
Table 6.8 Gore Medical Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Gore Medical Total Company Recent Development 2015-2019
Table 6.10 Microport Scientific Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Microport Scientific Corporation Products and Services (Product/Service, Segment)
Table 6.12 Microport Scientific Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Microport Scientific Corporation Total Company Recent Development 2015-2019
Table 6.14 MAQUET Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 MAQUET Products and Services (Product/Service, Segment)
Table 6.16 MAQUET Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 MAQUET Total Company Recent Development 2015-2019
Table 6.18 Lombard Medical Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Lombard Medical Products and Services (Product/Service, Segment)
Table 6.20 Lombard Medical Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Lombard Medical Total Company Recent Development 2015-2019
Table 6.22 JOTEC Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 JOTEC Products and Services (Product/Service, Segment)
Table 6.24 JOTEC Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 JOTEC Total Company Recent Development 2015-2019
Table 6.26 Endologix Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 Endologix Products and Services (Product/Service, Segment)
Table 6.28 Endologix Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 Endologix Total Company Recent Development 2015-2019
Table 6.30 Terumo Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 Terumo Corporation Products and Services (Product/Service, Segment)
Table 6.32 Terumo Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 Terumo Corporation Total Company Recent Development 2015-2019
Table 6.34 W.L. Gore and Associates Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 W.L. Gore and Associates Products and Services (Product/Service, Segment)
Table 6.36 W.L. Gore and Associates Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 W.L. Gore and Associates Total Company Recent Development 2015-2019
Table 6.38 Endologix, Inc., Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 Endologix, Inc., Products and Services (Product/Service, Segment)
Table 6.40 Endologix, Inc., Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 Endologix, Inc., Total Company Recent Development 2015-2019
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
